Image of the Day: Triple Threat

Scientists use stem-like cells from patients’ aggressive, triple receptor-negative breast tumors to grow cell lines for research.

By | September 18, 2017

Breast cancer stem cell line 1 (BCSC1), visualized by keratin 5 (green) and keratin 8 (red) proteins and nuclei (blue)MAURER LABSee E. Metzger et al., “KDM4 inhibition targets breast cancer stem-like cells,” Cancer Research, doi:10.1158/0008-5472.CAN-17-1754, 2017. 

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. The Rising Research Profile of 23andMe
    News Analysis The Rising Research Profile of 23andMe

    An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.